- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Advances in Virology
Volume 2011 (2011), Article ID 268214, 6 pages
Prevalence of XMRV Nucleic Acid and Antibody in HIV-1-Infected Men and in Men at Risk for HIV-1 Infection
1HIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702-1201, USA
2AIDS Research and Retrovirus Discovery, Abbott Laboratories, Abbott Park, IL 60064, USA
3Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
4Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA
5Feinberg School of Medicine, Northwestern University Chicago, IL 60611, USA
6Department of Molecular Biology and Microbiology, Tufts University, Boston, MA 02111, USA
Received 20 June 2011; Revised 8 August 2011; Accepted 22 August 2011
Academic Editor: Arifa S. Khan
Copyright © 2011 J. Spindler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- V. C. Lombardi, F. W. Ruscetti, J. Das Gupta et al., “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome,” Science, vol. 326, no. 5952, pp. 585–589, 2009.
- A. Urisman, R. J. Molinaro, N. Fischer et al., “Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant,” PLoS Pathogens, vol. 2, article e25, 2006.
- B. C. Satterfield, R. A. Garcia, H. Jia, S. Tang, H. Zheng, and W. M. Switzer, “Serologic and PCR testing of persons with chronic fatigue syndrome in the United States shows no association with xenotropic or polytropic murine leukemia virus-related viruses,” Retrovirology, vol. 8, article 12, 2011.
- O. Hohn, K. Strohschein, A. U. Brandt et al., “No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro,” PLoS One, vol. 5, no. 12, Article ID e15632, 2010.
- M. Cornelissen, F. Zorgdrager, P. Blom et al., “Lack of detection of XMRV in seminal plasma from HIV-1 infected men in The Netherlands,” PLoS One, vol. 5, no. 8, Article ID e12040, 2010.
- O. Erlwein, S. Kaye, M. O. McClure et al., “Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome,” PLoS One, vol. 5, no. 1, Article ID e8519, 2010.
- E. R. Gray, J. A. Garson, J. Breuer et al., “No evidence of XMRV or related retroviruses in a london HIV-1-positive patient cohort,” PLoS One, vol. 6, no. 3, Article ID e18096, 2011.
- M. Kearney and F. Maldarelli, “Current status of xenotropic murine leukemia virus-related retrovirus in chronic fatigue syndrome and prostate cancer: reach for a scorecard, not a prescription pad,” Journal of Infectious Diseases, vol. 202, no. 10, pp. 1463–1466, 2010.
- B. Oakes, A. K. Tai, O. Cingoz et al., “Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences,” Retrovirology, vol. 7, article 109, 2010.
- M. J. Robinson, O. W. Erlwein, S. Kaye et al., “Mouse DNA contamination in human tissue tested for XMRV,” Retrovirology, vol. 7, article 108, 2010.
- J. A. Garson, P. Kellam, and G. J. Towers, “Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection,” Retrovirology, vol. 8, article 13, 2011.
- S. Hué, E. R. Gray, A. Gall et al., “Disease-associated XMRV sequences are consistent with laboratory contamination,” Retrovirology, vol. 7, article 111, 2010.
- K. Knox, D. Carrigan, G. Simmons et al., “No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected,” Science, vol. 333, no. 6038, pp. 94–97, 2011.
- T. Paprotka, K. A. Delviks-Frankenberry, O. Cingöz et al., “Recombinant origin of the retrovirus XMRV,” Science, vol. 333, no. 6038, pp. 97–101, 2011.
- X. Qiu, P. Swanson, K. C. Luk et al., “Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies,” Retrovirology, vol. 7, article 68, 2010.
- E. Barnes, P. Flanagan, A. Brown et al., “Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections,” Journal of Infectious Diseases, vol. 202, no. 10, pp. 1482–1485, 2010.
- S. Tang, J. Zhao, R. Viswanath et al., “Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus Type 1-infected blood donors or individuals in Africa,” Transfusion, vol. 51, no. 3, pp. 463–468, 2011.
- N. Onlamoon, J. Das Gupta, P. Sharma et al., “Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV,” Journal of Virology, vol. 85, no. 9, pp. 4547–4557, 2011.
- S. Palmer, A. P. Wiegand, F. Maldarelli et al., “New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma,” Journal of Clinical Microbiology, vol. 41, no. 10, pp. 4531–4536, 2003.
- R. A. Furuta, T. Miyazawa, T. Sugiyama et al., “No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan,” Retrovirology, vol. 8, article 20, 2011.
- X. Qiu, P. Swanson, N. Tang, et al., “Prevalence of XMRV in blood donors, HTLV and HIV cohorts,” in Proceedings of the 15th International Conference on Human Retroviruses: HTLV and Related Viruses. Leuven, Belgium, June, 5-8, 2011.
- G. Simmons, S. A. Glynn, J. A. Holmberg et al., “The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans,” Transfusion, vol. 51, no. 3, pp. 643–653, 2011.
- R. S. Arnold, N. V. Makarova, A. O. Osunkoya et al., “XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH,” Urology, vol. 75, no. 4, pp. 755–761, 2010.
- R. Schlaberg, D. J. Choe, K. R. Brown, et al., “XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 38, pp. 16351–16356, 2009.
- B. P. Danielson, G. E. Ayala, and J. T. Kimata, “Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions,” Journal of Infectious Diseases, vol. 202, no. 10, pp. 1470–1477, 2010.
- K. J. Kunstman, T. Bhattacharya, J. Flaherty, et al., “Absence of xenotropic murine leukemia virus-related virus in blood cells of men at risk for and infected with HIV,” AIDS, vol. 24, no. 11, pp. 1784–1785, 2010.